|
|||||
| |
|
|
|||
|
LeukoSite, Inc. Realized NASDAQ: MLNM LeukoSite was founded in 1992 to develop new drugs designed to block disease-promoting actions of white blood cells. In 1999, LeukoSite merged with Millennium Pharmaceuticals, Inc. a leading biopharmaceutical company.
|
|||||
© 2001-10 PERSEUS, L.L.C., Designer: Beebe Comm. Site updated |
|||||